Kura Oncology's chart data is dated 2026-10-09. There is no active technical signal. There are 6 published signal records.
Kura Oncology last closed at $10.60 (+0.76%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -3.1×. Its overall grade ranks 633 of 738 stocks in Healthcare.
About this company
Kura Oncology last closed at $10.60 (+0.76%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall D · 633/738
Valuation grade C
Related stocks
- AmgenCompetitor
미국 혈액암·종양학 신약 개발에서 경쟁하는 대형 제약사
- Mirati TherapeuticsCompetitor
KRAS·표적항암제 개발 분야의 직접 경쟁 축에 있던 기업
- Revolution MedicinesCompetitor
RAS/MAPK 경로 표적 항암제 개발 경쟁사
ETFs holding this stock
Virtus LifeSci Biotech Products ETF
Details →About Kura Oncology
- What technical signals does Kura Oncology (KURA) have?
- Kura Oncology current technical signals: no active technical signal.
- Is Kura Oncology a cup-and-handle pattern?
- No. Kura Oncology has no valid Cup signal right now.
- What published figures are available for Kura Oncology?
- Market cap: $922.39M. Trailing 12 months PER: -3.1×. Latest quarter PBR: 19.30×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Kura Oncology, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.